Outlining Successful Steps for Scale-Up and BLA Filings
All partners, which could include biotechs, bio/ pharma companies, and CDMOs, must understand and agree on the goal, the process, the development plan (includSTÉPHANE ing potential deviations), production, and manufacturing. Starting a project with microbial fermentation is quicker and easier than u...
Gespeichert in:
Veröffentlicht in: | Biopharm International 2022-08, Vol.35 (8), p.22-26 |
---|---|
1. Verfasser: | |
Format: | Magazinearticle |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | All partners, which could include biotechs, bio/ pharma companies, and CDMOs, must understand and agree on the goal, the process, the development plan (includSTÉPHANE ing potential deviations), production, and manufacturing. Starting a project with microbial fermentation is quicker and easier than using mammalian cells because microbial cells are easier and more convenient to access. Because a plasmid is used in these situations, there is no need to select a particular clonal line; thus, the upstream function is easier and quicker when working with bacteria. Corrosive buffers can be prepared and used in single-use plastic bags for small batch production at an early stage, but, when it is time to move to larger stainless steel equipment, single-use bags cannot be used. [...]microbial manufacturing requires customized processes for each specific molecule, and, therefore, working with multiple partners can lead to potentially unwanted surprises, such as additional plant adaption, a higher level of capital expenditure, longer batch and cycle times, and a resultant higher cost of goods. |
---|---|
ISSN: | 1542-166X 1939-1862 |